Phase II Neoadjuvant ER+/PgR + Arimidex +/- Iressa Study
Clinical trial NCT00255463 · COMPLETED
Trial details
- NCT number
- NCT00255463
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-01-01
- Enrollment
- 185
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.